➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Baxter
Dow
McKinsey
Merck

Last Updated: October 1, 2020

DrugPatentWatch Database Preview

Details for Patent: 7,608,282

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which drugs does patent 7,608,282 protect, and when does it expire?

Patent 7,608,282 protects SANCUSO and is included in one NDA.

This patent has forty patent family members in thirty-one countries.

Summary for Patent: 7,608,282
Title:Transdermal granisetron
Abstract:Adhesive patches for the transdermal administration of granisetron, comprise an acrylic adhesive containing non-acidic nucleophilic moieties which substantially increase flux of granisetron across the skin.
Inventor(s): Altenschopfer; Peter (Ortenburg, DE), Watkinson; Adam Charles (Victoria, AU)
Assignee: Strakan International Limited (Hamilton, BM)
Application Number:10/544,259
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,608,282
Patent Claim Types:
see list of patent claims
Compound; Use;

Drugs Protected by US Patent 7,608,282

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Kyowa Kirin SANCUSO granisetron FILM, EXTENDED RELEASE;TRANSDERMAL 022198-001 Sep 12, 2008 RX Yes Yes   Start Trial   Start Trial Y USE OF GRANISETRON TRANSDERMAL SYSTEM TO TREAT/PREVENT CHEMOTHERAPY INDUCED NAUSEA AND VOMITING   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,608,282

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0302662.2Feb 05, 2003
PCT Information
PCT FiledFebruary 05, 2004PCT Application Number:PCT/GB2004/000403
PCT Publication Date:August 19, 2004PCT Publication Number: WO2004/069141

International Family Members for US Patent 7,608,282

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 368454   Start Trial
Australia 2004210181   Start Trial
Brazil PI0407280   Start Trial
Canada 2515094   Start Trial
China 102416009   Start Trial
China 102526043   Start Trial
China 1747724   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
McKinsey
McKesson
Dow
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.